title: Circadian rhythms of tumor markers in breast cancer patients.
authors.affiliation: Department of Biochemistry, Faculté de Médecine Pitié-Salpétrière, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Touitou
authors.forename: F
authors.initials: F
authors.lastname: Bailleul
authors.forename: F
authors.initials: F
authors.lastname: Lévi
authors.forename: A
authors.initials: A
authors.lastname: Bogdan
authors.forename: C
authors.initials: C
authors.lastname: Touitou
authors.forename: G
authors.initials: G
authors.lastname: Metzger
authors.forename: M
authors.initials: M
authors.lastname: Mechkouri
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000556:secondary; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D001798:Blood Proteins / Q000378:metabolism; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000097:blood; D002940:Circadian Rhythm / Q000502:physiology*; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D001798:Blood Proteins; D002272:Carcinoembryonic Antigen; D004317:Doxorubicin; D006854:Hydrocortisone